InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,067.18
(
1.13%
)
US TECH 100
16,964.00
(
1.26%
)
Dow Jones
38,468.68
(
0.60%
)
Brent Oil
87.17
(
0.87%
)
Bitcoin
66,739.63
(
-0.18%
)
Post# of 251566
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 826
Posts 119449
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 115714

Tuesday, 05/03/2011 2:59:42 PM

Tuesday, May 03, 2011 2:59:42 PM

Post# of 251566
Ipsen’s 1Q11 worldwide Dysport sales were €50.1M, +15% QoQ, +19% YoY (in local currencies):

http://finance.yahoo.com/news/Ipsens-first-quarter-2011-bw-2108649996.html?x=0&.v=1

Dysport, which is sold by MRX for cosmetic indications in the US, continues to be a very distant second to Botox in both medical and cosmetic indications. AGN reports 1Q11 Botox sales tomorrow.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up